'The lower level of anticipated sales to Stryker in 2008 is clearly disappointing but we, as does Stryker, remain confident that the potential for Cormet in the world's largest orthopaedic market is substantial.'

This was 600p at one stage, started falling and then after the above statement. I recall that a broker downgraded target price to 300p.

Cheap at 160p?

any comments on this...looks interesting for a rise back up?

hmmm looks to be waking up...as always DYOR

up 9% now...on the leaderboard, may get even more attention as a result IMHO

thx 4 highlighting...prob is that all stocks look undervalued only to become even cheaper the day after...crazy markets currently!

no surprise...cheaper than they were yesterday....crazy!

maybe worth a punt since now at float price which surely has to be ridiculous considering cormet potential and distribution deal with stryker and any possible bids circling, below quote is from ft.com in March 2008...

'Julie Simmonds, analyst at Piper Jaffray, says Corin's push into the US was likely to gather momentum as more surgeons were trained to instal its devices. She says: "Corin has managed to break into the US market and the key to the company is the growth potential in the US.

"Corin has some good technology and the deal with Stryker is on good terms."

Corin's break into the US helped its shares to an all-time high of 635p in October, and the group closed 2007 up 87 per cent on the year.

This compares with a price of 111p when the company was floated in the London Stock Exchange in 2002.

Although pre-tax profits for 2006 were a modest 3.6m, analysts expect growth to accelerate during the next few years. Oriel Securities is forecasting pre-tax profits of 5.6m for 2007, rising to 22m by 2009.'

PLEASE DYOR

have gone LONG on this since no profit/potential/bid priced in

intra-day reversal in progress

:-)

OXB, GWP, PRM all doing well today, SN. announced bumper results and looking strong

CRG alot of catching up, don't forget this quality stock

just starting to move now...

results out in less than 2 weeks...

worth thinking about Corin's products and the value in their intellectual property, market penetration and FDA approvals. This is a business with high barriers to entry...DYOR

don't forget these are a possible takeover target, their distributor has already shown interest in them...L2 getting stronger

edging higher

Corin Group PLC (LSE: CRG), a leading manufacturer and supplier of orthopaedic devices, will publish its Interim Results for the six months ended 30 June 2008, on Thursday, 28 August 2008.

Watch this space...this will rocket, when it becomes clear that things are improving, recently there were rumours of takeover and rumour of tie-up - DYOR.

poised to move northwards

SS been following some of your comments on stocks, impressive.

Advise a read of the Interim Management System 14/5 and then you will appreciate how oversold this share really is. Analysts reduced their target to 300p back then, incredibly cheap now.

Results out in 8 trading days.

Look at SN. to see how well the sector is performing.

Extracted from a recent update from SN. 'Smith & Nephew's results follow a strong quarter of growth from rivals such as U.S.-based Stryker Corp and Switzerland's Synthes .'

All bodes very well for CRG as the recovery takes shape. Don' forget that Stryker have been targetting a takeover of CRG. Even, in the absence of a bid, an analyst was valuing these at 300p. Their FDA approval and products are worth more than this current SP reflects. DYOR

just a matter of time before the SP reacts northwards IMHO (SN. still going higher)

SN. should think about buying CRG, since both of them have FDA approval and CRG have a distribution deal with Stryker, so this will just give them another notch up in the sector. CRG undervalued, even with US sales not expected to be above 10M, the overall revenue situation is still positive and strong compared to pre-cormet and the SP was higher back then. The market will realise eventually, most likely when you run a ruler over the numbers next week, prompting upgrades and then all the buyers will come flooding in.

rising on such a red day...excellent time to buy in before the rise is vertical

start your engines...enjoy the ride :-)

minimum downside IMHO, look at the chart for all the upside and that recent spike towards 180p

position 22 on the Top % gainers list

should get even more attention tomorrow

from the news at 15:31 from moneyam 'Turning to the upside, Smith & Nephew was the top riser, up almost 3 percent, or 18 pence, at 636-1/2 after traders noted revived speculation that the orthopaedics firm could be a bid target for U.S. peer Zimmer Holdings Inc.'

CRG in the same sector, could be taken out on the cheap at say 300p - yes over double the current price! Remember an Analyst valued them at 300p if not a bid target! Cheap to say the least at the current SP IMHO

Please DYOR.

expecting an even larger rise than 7% tomorrow

from Ft.com 'Smith & Nephew was the day's main speculative feature on a revival of gossip that it could be a takeover target for Zimmer, its US orthopaedics peer.

Analysts saw some logic to the tale. S&N's hip resurfacing system would fill a gap for Zimmer, which last month delayed its rival product. S&N's latest results provided clarity about the possible cost of an investigation into its Plus division. Its shares rose 2.2 per cent to 632p, but bankers doubted contact had been made.'

Hello - Zimmer have a look at CRG, undervalued!

Read the morning paper round up...Zimmer bid mentioned in 5 of the newspapers, bodes well for CRG also IMHO.

No more posts from me, talking to myself!

alot more for these to rise, very early stages

BUY IMHO!

Corin Group H1 pretax profit up on higher revenues
AFX


LONDON (Thomson Financial) - Corin Group Plc., the UK orthopaedics manufacturer, said its first-half pretax profit rose 55 percent on a 63 percent rise in sales, reflecting the initial roll out of Cormet, its leading hip resurfacing product, in the United States.

'We remain confident of Cormet success in the U.S., although over a longer timeframe than previously anticipated,' Corin said.

It said it has made an encouraging start to the second half, with sales in line with the board's expectations.

For the six months to end-June, the pretax profit rose to 1.8 million pounds from 1.2 million pounds as sales increased to 22.9 million pounds from 14.0 million pounds.

level 2 looks weak, this looks like it will fall further and nothing positive for the remainder of 2008 from the results released, back down to 100p?

42% fall on news that US orthapedic sales are unlikely to materialise in the financial year. (despite favourable exchange-rates)
+Also some mention similar in UK.
This looks a tad careless to be in a business that is so product-dependent - What's most likley is that a competitor has a better product - anyone?
Currently 78p to buy...

And so it keeps on falling difficult to put a value on.

ZERO comes to mind!

I was going to say exactly the same thing.

However, we shouldn't upset existing shareholders you know.

why not?

Because they might start picking on the companies I've got where the sp has collapsed!

tell me, tell me ...... i need another target - lol!

shut up or I shall start talking about TAN to you!

;-)

don't care! ..... don't hold it any more

Though you bought at just over the quid mark.

When did you shift it?

after my bollocks were put in a vice!

lol

Confess I got in after the results at 10p hoping for a quick in-and-out and failed rather pathetically. Got well shafted by the MM's.

Take a look a PHTM its a winner.

so was Foinavon - lol!
not in the mood for buying, though at least PHTM has an acceptable spread.
no news to give a clue as to surge, but of course very small cap so always a hostage to any volume

Its a funny stock but in the past its 10 bagged in 12 months its that kind of stock..

Corin on the otherhand is overvalued.

Investors Chronic has told readers to Sell this Friday .

how much is a Friday fetching nowadays?

Less than Thursday.

Any ideas how low this will go..

thinking of shorting it then?

No position here cynic its a hard one to value as you know.

not worth the effort

I agree.

Down 10% to 45p today not worth the bother.. yet.